1-9 of 9
Michael D. Jain
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Munoz, Razan Mohty, Veit L. Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1857–1868.
https://doi.org/10.1182/bloodadvances.2023011767
Published: 2024
Includes: Supplemental data
Journal Articles

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Clinical Trials & Observations
Michael D. Jain, Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwole, Joseph McGuirk, Abhinav Deol, Alison R. Sehgal, Andre Goy, Brian T. Hill, Charalambos Andreadis, Javier Munoz, Julio C Chavez, N. Nora Bennani, Aaron P. Rapoport, Julie M. Vose, David Miklos, Sattva S. Neelapu, Frederick L. Locke, Armin Ghobadi
Journal: Blood Advances
Blood Adv (2024) 8 (4): 1042–1050.
https://doi.org/10.1182/bloodadvances.2023011489
Published: 2024
Includes: Supplemental data
Journal Articles

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Erin A. Dean, Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed M. Hossain, Michael D. Jain, Saurabh Dahiya, David B. Miklos, Philipp M. Altrock, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4608–4618.
https://doi.org/10.1182/bloodadvances.2022009426
Published: 2023
Journal Articles

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Christelle M. Colin-Leitzinger, Alexandria M. Shrewsbury, Hitomi Hosoya, Rebecca M. Gonzalez, Christina Copponex, Krista H. Kottra, Vanna Hovanky, Bita Sahaf, Sunita Patil, Aleksandr Lazaryan, Michael D. Jain, Aliyah Baluch, Olga V. Klinkova, Nelli Bejanyan, Rawan G. Faramand, Hany Elmariah, Farhad Khimani, Marco L. Davila, Asmita Mishra, Brandon J. Blue, Ariel F. Grajales-Cruz, Omar A. Castaneda Puglianini, Hien D. Liu, Taiga Nishihori, Ciara L. Freeman, Jason B. Brayer, Kenneth H. Shain, Rachid C. Baz, Frederick L. Locke, Melissa Alsina, Surbhi Sidana, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6109–6119.
https://doi.org/10.1182/bloodadvances.2022008320
Published: 2022
Includes: Supplemental data
Journal Articles

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL

Ariel Perez, Grace Johnson, Kedar Patel, Brian Arciola, Anthony Wood, Christina A. Bachmeier, Julio C. Chavez, Bijal D. Shah, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Marco L. Davila, Rahul Mhaskar, Frederick L. Locke, Sameh Gaballa, Michael D. Jain
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3970–3973.
https://doi.org/10.1182/bloodadvances.2022007006
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

Clinical Trials & Observations
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, Jongphil Kim, Brian Christopher Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A. Kharfan-Dabaja, Frederick L. Locke, Rebecca Gonzalez, Michael D. Jain, Marco L. Davila, Lia Elena Perez, Asmita Mishra, Ariel Perez Perez, Karlie Balke, Ernesto Ayala, Leonel Ochoa, Omar Castaneda Puglianini, Rawan Faramand, Melissa Alsina, Hany Elmariah, Michael L. Nieder, Hugo Fernandez, Claudio Anasetti, Joseph A. Pidala
Journal: Blood Advances
Blood Adv (2022) 6 (1): 259–269.
https://doi.org/10.1182/bloodadvances.2021005552
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021
Journal Articles

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma

Clinical Trials & Observations
Hamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, Constantine Logothetis, Franco Garcia, Anuhya Kommalapati, Rahul S. Mhaskar, Christina Bachmeier, Julio C. Chavez, Bijal Shah, Javier Pinilla-Ibarz, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Marco L. Davila, Frederick L. Locke, Taiga Nishihori, Michael D. Jain
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4086–4090.
https://doi.org/10.1182/bloodadvances.2020002060
Published: 2020
Includes: Supplemental data
Journal Articles

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Erin A. Dean, Rahul S. Mhaskar, Hong Lu, Mina S. Mousa, Gabriel S. Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chavez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3268–3276.
https://doi.org/10.1182/bloodadvances.2020001900
Published: 2020
Includes: Supplemental data